TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
05/14/2026
Back to search
Official data from USPTO
PRIOVANT
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
PRIOVANT
ST13
US500000097261339Class
5, 42, 44
Filing
97261339
Registration
6924850
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
32
Latest update
05/16/2026
Trademark type
Word
Nice classes
5, 42, 44
Filing date
02/10/2022
Registration date
12/13/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/13/2022
Last transaction
05/16/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Foreign priority
Drawing code
4
Owner type
03
Owner location
Durham, NC, US
Examiner
SINGH, TEJBIR
Law office
L60
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
PRIOVANT THERAPEUTICS, INC.
Roivant Sciences GmbH
Representatives
Lisa L. Mueller Casimir Jones, S.C.
Technical classification
Nice Classes
Class 5Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for human usefor the prevention and treatment of immunologicalauto-immunerheumatologicaldermatological and oncological diseases and disorders; biological preparations for medical and therapeutic purposesfor the prevention and treatment of immunologicalauto-immunerheumatologicaldermatological and oncological diseases and disorders
Class 42
Scientific and technological servicesmedical researchscientific research and analysis in the fields of pharmaceutical and biomedicine; pharmaceutical and biomedical research services; research in the field of pharmaceutical and biologic therapeutic preparations; pharmaceutical research and development; providing scientific research information in the field of pharmaceuticals and biomedicine
Class 44
Providing health and medical information; providing information relating to the diagnosticprophylactic and therapeutic properties of pharmaceutical preparations and biologic preparations for the prevention and treatment of diseasesdisorders and conditions
Publications
History of USPTO decisions and trademark events.
32 publications found
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
05/14/2026
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
05/14/2026
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
05/14/2026
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
05/14/2026
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
03/01/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
03/01/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
03/01/2024
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
09/13/2023
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
12/13/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
12/13/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/27/2022
PUBO
PUBLISHED FOR OPPOSITION
09/27/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/07/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/18/2022
XAEC
EXAMINER'S AMENDMENT ENTERED
08/17/2022
ALIE
ASSIGNED TO LIE
08/17/2022
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
08/17/2022
GNEA
EXAMINERS AMENDMENT E-MAILED
08/17/2022
CNEA
EXAMINERS AMENDMENT -WRITTEN
08/17/2022
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
07/21/2022
GNFR
FINAL REFUSAL E-MAILED
07/21/2022
CNFR
FINAL REFUSAL WRITTEN
07/21/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/14/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/13/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/13/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
04/27/2022
GNRT
NON-FINAL ACTION E-MAILED
04/27/2022
CNRT
NON-FINAL ACTION WRITTEN
04/27/2022
DOCK
ASSIGNED TO EXAMINER
04/27/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/15/2022
NWAP
NEW APPLICATION ENTERED
02/14/2022
Continuous trademark protection
Get notified about every new filing that threatens PRIOVANT or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.